PBA
MRTX
Paradigm Biocapital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,543,116
| Closed | -$90.7M | – | 39 |
|
|
2023
Q4 | $90.7M | Sell |
1,543,116
-125,000
| -7% | -$7.34M | 4.24% | 11 |
|
|
2023
Q3 | $72.7M | Buy |
1,668,116
+224,354
| +16% | +$9.77M | 4.93% | 7 |
|
|
2023
Q2 | $52.2M | Buy |
1,443,762
+46,983
| +3% | +$1.7M | 4.03% | 10 |
|
|
2023
Q1 | $51.9M | Buy |
1,396,779
+128,809
| +10% | +$4.79M | 4.92% | 9 |
|
|
2022
Q4 | $57.5M | Buy |
1,267,970
+417,585
| +49% | +$18.9M | 6.74% | 3 |
|
|
2022
Q3 | $59.4M | Buy |
850,385
+190,417
| +29% | +$13.3M | 7.92% | 2 |
|
|
2022
Q2 | $44.3M | Buy |
659,968
+561,585
| +571% | +$37.7M | 8.83% | 3 |
|
|
2022
Q1 | $8.09M | Sell |
98,383
-161,732
| -62% | -$13.3M | 2.14% | 19 |
|
|
2021
Q4 | $38.2M | Buy |
+260,115
| New | +$38.2M | 10.9% | 1 |
|